Research field (2)：
Pharmacology
, Pharmaceuticals - health and biochemistry
Research keywords (4)：
TLRリガンド
, アジュバント
, 腫瘍免疫
, Cancer Immunotherapy
Research theme for competitive and other funds (8)：
2021 - 2024 腫瘍微小環境の理解に基づく効果的な治療法の開発
2020 - 2023 Identification of vaccine immunogenic factors for in situ cancer vaccine strategy
2017 - 2020 Development of the lipopeptide based antitumor immunoadjuvants by drug design
2012 - 2016 Development of designed TLR2 ligand as antitumor immunoadjuvant
2009 - 2010 Development of synthetic adjuvants by biological drug design
2008 - 2010 Development of a useful tool adding a microbial component to tumor cell as vaccine adjuvant
2007 - 2008 Reconstruction of BCG-CWS activity for cancer immunotherapy
2003 - 2004 機能的設計に基づいた人工アジュバントの開発
Show all
Papers (40)：
Shunichi Watanabe, Ayaka Takagi, Eiji Yuba, Chie Kojima, Nanako Dei, Akikazu Matsumoto, Jun Tanikawa, Tetsuya Kawamura, Nadeeka H. De Silva, Takeshi Izawa, et al. In vivo transfection of cytokine genes into tumor cells using a synthetic vehicle promotes antitumor immune responses in a visceral tumor model. The FASEB Journal. 2023. 37. 11
